sitafloxacin sitafloxacin sitafloxacin (inn; also called du-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of buruli ulcer. the molecule was identified by daiichi sankyo co., which brought ofloxacin and levofloxacin to the market. sitafloxacin is currently marketed in japan by daiichi sankyo under the tradename gracevit. sitafloxacinclinical dataroutes ofadministrationoralatc codej01ma21 (who) legal statuslegal status in general: ℞ (prescription only) identifiers iupac name 7-heptan-6-yl]-8-chloro-6-fluoro-1--4-oxoquinoline-3-carboxylic acid cas number127254-12-0 npubchem cid461399chemspider405945 yunii3gjc60u4q8keggd02475 nchemblchembl108821 ycomptox dashboard (epa)dtxsid5048847 chemical and physical dataformulac19h18clf2n3o3molar mass409.81 g·mol−13d model (jsmol)interactive image smiles f5c5n2/c=c(/c(=o)o)c(=o)c1cc(f)c(c(cl)c12)n4c(n)c3(cc3)c4 inchi inchi=1s/c19h18clf2n3o3/c20-14-15-8(17(26)9(18(27)28)5-25(15)12-4-10(12)21)3-11(22)16(14)24-6-13(23)19(7-24)1-2-19/h3,5,10,12-13h,1-2,4,6-7,23h2,(h,27,28)/t10-,12+,13+/m0/s1 ykey:pnuzdkcdawuegk-cyzmbnfosa-n y ny (what is this?) (verify)